Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Acquisition

30 Jun 2006 07:01

London Asia Chinese Private Equity30 June 2006 30 June 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Three new investments LACPEF, the China focused investment fund, announces that it has committed tomake three new investments, for a total consideration of £6.9 million in cash. The Fund is investing £1.9 million in China New Energy Ltd ("CNE"), a leadingturnkey provider of production equipment and technologies for ethanol productionin China; £2.9 million in China Synergy Real Estate Limited ("Synergy"), aleading real estate services firm based in Beijing; and £2.1 million in ChinaBiofoods, a health food products company. China New Energy: CNE's core business is the supply of turnkey technology solutions for theproduction of ethanol, edible alcohol and acetic acid from a range ofbio-resources, including corn, sugarcane, cassava and other bio-resources. CNE has established itself as the leading brand in China, with an estimated 60%share of the market for ethanol production equipment in China. The Company'ssuccessful track record is key to growing the business and its leadingtechnology has been used in over 30 projects. CNE is supported by strong driverswith the demand for ethanol, a fuel seen as an alternative to oil, still growingand supported by a new legislative framework requiring 10% of all vehicle oilconsumption to be biofuel in 11 of China's Provinces. For the year ended 31 December 2005 CNE reported profit after tax of £1.9m(2004: £0.6m) on sales of £8.7m (2004: £3.1m). Based in Guangzhou, it wasfounded in June 2002 as a spin-out from the Renewable Energy division of China'sAcademy of Science, the leading Government funded centre in China for thedevelopment of renewable energy technology. CNE currently has 72 employees and following the investment from the fund, SimonLittlewood and Victor Ng, managers of the Fund, will take a seat on theCompany's board. China Synergy: Synergy is the second largest real estate broker in the northern China market.Founded 10 years ago in Beijing, China, the Company provides agency, consultancyand conveyance services for property developers in China including internationalproperty investors Carlyle Partners and Lehman Bros. The Company focuses ondeals with residential and commercial properties at the top end of the market,and has advised on 60 projects. Synergy was named as "Agency of the Year" in "New Real Estate", the industrymagazine, and in the Top 20 Real Estate Agencies in China" in 2005 by "SINA.com". For the year ended 31 December 2005 Synergy reported profit after tax of £2.1mon turnover of £4.9m, up 58% and 38% respectively on 2004. Simon Littlewoodwill be appointed to the Synergy Board following investment. China Biofoods: China Biofoods is based in Xuchang, Henan Province, the centre for farmingtraditional Chinese medical herbs. It specialises in the production of highlypurified herb extract products which are then used to produce traditionalChinese medicine, and as ingredients in functional foods. The market for "Functional Foods" is expanding rapidly worldwide, especially inChina. "Functional Foods" are foods or dietary components that may provide ahealth benefit beyond their basic nutritional value. China Biofoods' core products are highly purified linolenic acids, Reshimushroom spore oil, and deodorized garlic oil. Linolenic acid, also known asVitamin F, is an essential fatty acid which is not produced by the body, and hasbeen proven to improve hair and skin, reduce blood pressure, help preventarthritis, lower cholesterol & triglycerides and reduce the risk of blood clots. Reshi mushroom spore oil is broadly used in the health food industry as asupplement and intermediate ingredient. In 2005 China Biofoods reported revenues of £2.9m with profit after tax of£1.2m. The Fund will appoint a representative to the China Biofoods Boardfollowing investment. Victor Ng, Director of LACPEF, commented: "All three companies presented atLondon Asia's China Seminar in London earlier this month. There was stronginterest from investors as all three sectors are showing considerable growth onthe back of China's continued economic development. CNE is the leading playerin is field and has significant growth potential as China seeks to developrenewable energy sources and reduce its reliance on expensive imported fossilfuels. Synergy is taking advantage of the switch from public and subsidisedhousing to the development of a private housing market in China, with theBeijing market seeing additional impetus from the 2008 Olympics. ChinaBiofoods' products appeal to the increasingly affluent Chinese population, whohave more money to spend than in the past and are becoming more healthconscious, particularly as a result of the one child policy and the ageing ofthe population" Simon Littlewood, Director of LACPEF, added: "The Fund has now made fiveinvestments, totalling £9.3 million. There is potential to make follow oninvestments in those deals as the companies develop and we also have a number ofother deals which we expect to close in the near future." For further information please visit www.londonasiafunds.com or contact:John West/Matt Ridsdale Simon Littlewood Hugh FieldTavistock Communications London Asia Capital plc Collins Stewart LimitedTel: 020 7920 3150 Tel: 020 7355 7928 Tel: 020 7523 8000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jul 20187:00 amRNSAgreement
19th Jul 201812:40 pmRNSFurther investment in Intensity Therapeutics Inc.
9th Jul 201811:17 amRNSIncreased holding in Fralis LLC (Leap Gaming)
6th Jul 20185:44 pmRNSResults for the year ended 31st March 2018
22nd Jun 20182:30 pmRNSInvestment in Vogogo Inc. Conv. Debenture Units
20th Jun 20186:20 pmRNSInvestee Company Update
19th Jun 20187:00 amRNSInvestment in Juvenescence Limited
12th Jun 20187:00 amRNSInvestee Company Update: Subscription into Fralis
11th Jun 20189:53 amRNSSale of Aphria Shares
16th May 20187:00 amRNSRegulatory Approval
23rd Mar 20183:35 pmRNSInvestee Company Update: Nuuvera Inc.
21st Mar 20181:28 pmRNSInvestee Company Update: Nuuvera
12th Mar 20181:00 pmRNSKey Investor Document
7th Mar 20182:34 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSProposed Director's Dealing
27th Feb 20183:43 pmRNSInvestee Company Update: Intensity Therapeutics
26th Feb 20184:01 pmRNSInvestee Company Update: Nuuvera
20th Feb 20183:26 pmRNSInvestee Company Update: Nuuvera
13th Feb 201812:22 pmRNSDirector Appointment
13th Feb 201812:05 pmRNSResult of AGM
12th Feb 20184:51 pmRNSTransaction in Own Shares
6th Feb 20189:37 amRNSCorrection of Notice of AGM
2nd Feb 20189:35 amRNSInvestee Company Update: Vemo
31st Jan 201811:04 amRNSTransaction in Own Shares
30th Jan 20185:00 pmRNSNotice of AGM
30th Jan 20184:20 pmRNSNotice of AGM
30th Jan 20188:35 amRNSHolding(s) in Company
29th Jan 20181:33 pmRNSInvestee Company Update: Nuuvera
23rd Jan 20182:43 pmRNSExtension of Share Buy-back Programme
23rd Jan 20181:19 pmRNSTransaction in Own Shares
18th Jan 20183:18 pmRNSInvestment Company Updates: Nuuvera
16th Jan 20183:36 pmRNSInvestee Company Update: Nuuvera
12th Jan 20183:43 pmRNSInvestee Company Update: Nuuvera
12th Jan 20182:23 pmRNSInvestee Company Update: Nuuvera
11th Jan 20188:00 amRNSInvestee Company Update: Nuuvera
8th Jan 20187:00 amRNSInvestee Company Update: Nuuvera
2nd Jan 201811:26 amRNSInvestee Company update: Nuuverra transaction
28th Dec 20173:29 pmRNSHalf-year Report
15th Dec 20179:23 amRNSCompany Secretary Change
15th Dec 20177:00 amRNSInvestee Company Update: Nuuvera
29th Nov 20174:14 pmRNSTransaction in Own Shares
29th Nov 20177:00 amRNSHolding(s) in Company
28th Nov 20174:06 pmRNSTransaction in Own Shares
23rd Nov 201710:12 amRNSHolding(s) in Company
20th Nov 201710:30 amRNSShare Buy-Back Programme
20th Nov 20179:56 amRNSMarket Update
3rd Nov 201712:00 pmRNSInvestee Company Update
9th Oct 20177:00 amRNSUpdate on Nuuverra Investment
18th Sep 20177:00 amRNSDisposal of interest in investee company
15th Aug 20177:00 amRNSInvestee Company Update: Schoold

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.